Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5h-2,3-benzodiazepine
2. Dextofisopam
3. Egyt-341
4. Grandaxin
5. Tofisopam
6. Tofizopam
1. (s)-tofisopam
2. 11zyl7qk34
3. 82059-51-6
4. (-)-(5s)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5h-2,3-benzodiazepine
5. Levotofisopam [usan]
6. Levotofisopam [usan:inn]
7. Unii-11zyl7qk34
8. Levotofisopam [inn]
9. Levotofisopam (usan/inn)
10. Schembl5431173
11. Chembl2107351
12. Zinc3831552
13. D04721
14. Q27251353
15. (5s)-1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5h-2,3-benzodiazepine
16. 5h-2,3-benzodiazepine, 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-, (5s)-
17. 5h-2,3-benzodiazepine, 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl, (5s)-
| Molecular Weight | 382.5 g/mol |
|---|---|
| Molecular Formula | C22H26N2O4 |
| XLogP3 | 3.2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 382.18925731 g/mol |
| Monoisotopic Mass | 382.18925731 g/mol |
| Topological Polar Surface Area | 61.6 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 579 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antidepressive Agents
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)
Market Place
ABOUT THIS PAGE
A Levotofisopam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levotofisopam, including repackagers and relabelers. The FDA regulates Levotofisopam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levotofisopam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levotofisopam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levotofisopam supplier is an individual or a company that provides Levotofisopam active pharmaceutical ingredient (API) or Levotofisopam finished formulations upon request. The Levotofisopam suppliers may include Levotofisopam API manufacturers, exporters, distributors and traders.
click here to find a list of Levotofisopam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Levotofisopam Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levotofisopam GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levotofisopam GMP manufacturer or Levotofisopam GMP API supplier for your needs.
A Levotofisopam CoA (Certificate of Analysis) is a formal document that attests to Levotofisopam's compliance with Levotofisopam specifications and serves as a tool for batch-level quality control.
Levotofisopam CoA mostly includes findings from lab analyses of a specific batch. For each Levotofisopam CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levotofisopam may be tested according to a variety of international standards, such as European Pharmacopoeia (Levotofisopam EP), Levotofisopam JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levotofisopam USP).
LOOKING FOR A SUPPLIER?
